{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:47:04Z","timestamp":1788479224835,"version":"build-2803163510"},"reference-count":82,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012648","name":"Oberkotter Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012648","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastrointestinal Endoscopy Clinics of North America"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.giec.2024.12.009","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T04:01:41Z","timestamp":1737691301000},"page":"855-867","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Immunology in Celiac Disease"],"prefix":"10.1016","volume":"35","author":[{"given":"Eric","family":"Marietta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rok Seon","family":"Choung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Rubio-Tapia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.giec.2024.12.009_bib1","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00281-012-0314-z","article-title":"The adaptive immune response in celiac disease","volume":"34","author":"Qiao","year":"2012","journal-title":"Semin Immunopathol"},{"issue":"2\u20133","key":"10.1016\/j.giec.2024.12.009_bib2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.humimm.2020.01.006","article-title":"Celiac disease risk stratification based on HLA-DQ heterodimer (HLA-DQA1 \u223c DQB1) typing in a large cohort of adults with suspected celiac disease","volume":"81","author":"Choung","year":"2020","journal-title":"Hum Immunol"},{"issue":"2","key":"10.1016\/j.giec.2024.12.009_bib3","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.3390\/ijms24021188","article-title":"Meta-analysis and systematic review of HLA DQ2\/DQ8 in adults with celiac disease","volume":"24","author":"Aboulaghras","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"Database issue","key":"10.1016\/j.giec.2024.12.009_bib4","doi-asserted-by":"crossref","first-page":"D913","DOI":"10.1093\/nar\/gkq1128","article-title":"Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations","volume":"39","author":"Gonzalez-Galarza","year":"2011","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"10.1016\/j.giec.2024.12.009_bib5","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.dld.2014.08.002","article-title":"Co-localization of gluten consumption and HLA-DQ2 and -DQ8 genotypes, a clue to the history of celiac disease","volume":"46","author":"Lionetti","year":"2014","journal-title":"Dig Liver Dis"},{"issue":"10","key":"10.1016\/j.giec.2024.12.009_bib6","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/ni.1780","article-title":"Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation","volume":"10","author":"Fallang","year":"2009","journal-title":"Nat Immunol"},{"issue":"9","key":"10.1016\/j.giec.2024.12.009_bib7","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1007\/s10620-014-3143-1","article-title":"Clinical utility of celiac disease-associated HLA testing","volume":"59","author":"Pallav","year":"2014","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.giec.2024.12.009_bib8","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1073\/pnas.1615973114","article-title":"Trogocytosis of peptide\u2013MHC class II complexes from dendritic cells confers antigen-presenting ability on basophils","volume":"114","author":"Miyake","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.giec.2024.12.009_bib9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/ACI.0b013e328334f693","article-title":"Eosinophils as antigen-presenting cells in allergic upper airway disease","volume":"10","author":"Akuthota","year":"2010","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.giec.2024.12.009_bib10","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.4049\/jimmunol.1102654","article-title":"Human gammadelta T lymphocytes are licensed for professional antigen presentation by interaction with opsonized target cells","volume":"188","author":"Himoudi","year":"2012","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.giec.2024.12.009_bib11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jaci.2017.05.029","article-title":"Human mast cells as antigen-presenting cells: when is this role important in vivo?","volume":"141","author":"Galli","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.giec.2024.12.009_bib12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jaci.2017.02.048","article-title":"Human mast cells present antigen to autologous CD4(+) T cells","volume":"141","author":"Lotfi-Emran","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"14","key":"10.1016\/j.giec.2024.12.009_bib13","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1182\/blood-2016-10-744441","article-title":"Neutrophils acquire the capacity for antigen presentation to memory CD4(+) T cells in vitro and ex vivo","volume":"129","author":"Vono","year":"2017","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.giec.2024.12.009_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183594","article-title":"The MHC class II antigen presentation pathway in human monocytes differs by subset and is regulated by cytokines","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.giec.2024.12.009_bib15","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.4049\/jimmunol.161.4.1585","article-title":"Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity","volume":"161","author":"van de Wal","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.giec.2024.12.009_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2021.112584","article-title":"Ranking of immunodominant epitopes in celiac disease: identification of reliable parameters for the safety assessment of innovative food proteins","volume":"157","author":"Vriz","year":"2021","journal-title":"Food Chem Toxicol"},{"issue":"4","key":"10.1016\/j.giec.2024.12.009_bib17","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1084\/jem.191.4.603","article-title":"The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase","volume":"191","author":"Arentz-Hansen","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.giec.2024.12.009_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/srep45092","article-title":"Quantitation of the immunodominant 33-mer peptide from alpha-gliadin in wheat flours by liquid chromatography tandem mass spectrometry","volume":"7","author":"Schalk","year":"2017","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.giec.2024.12.009_bib19","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.4049\/jimmunol.1601693","article-title":"T cells in celiac disease","volume":"198","author":"Jabri","year":"2017","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.giec.2024.12.009_bib20","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1007\/s10875-013-9920-3","article-title":"Colonic involvement in celiac disease and possible implications of the sigmoid mucosa organ culture in its diagnosis","volume":"33","author":"Picarelli","year":"2013","journal-title":"J Clin Immunol"},{"issue":"9","key":"10.1016\/j.giec.2024.12.009_bib21","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/ncpgasthep0582","article-title":"Mechanisms of disease: immunopathogenesis of celiac disease","volume":"3","author":"Jabri","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"issue":"7796","key":"10.1016\/j.giec.2024.12.009_bib22","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41586-020-2003-8","article-title":"IL-15, gluten and HLA-DQ8 drive tissue destruction in coeliac disease","volume":"578","author":"Abadie","year":"2020","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.giec.2024.12.009_bib23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11894-020-0756-8","article-title":"Refractory celiac disease","volume":"22","author":"Hujoel","year":"2020","journal-title":"Curr Gastroenterol Rep"},{"issue":"1","key":"10.1016\/j.giec.2024.12.009_bib24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.clim.2007.09.002","article-title":"Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease","volume":"126","author":"Verbeek","year":"2008","journal-title":"Clin Immunol"},{"issue":"19","key":"10.1016\/j.giec.2024.12.009_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251910383","article-title":"Refractory celiac disease: what the gastroenterologist should know","volume":"25","author":"Verdelho Machado","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.giec.2024.12.009_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.633436","article-title":"Regulatory dendritic cells, T cell tolerance, and dendritic cell therapy for immunologic disease","volume":"12","author":"Ness","year":"2021","journal-title":"Front Immunol"},{"issue":"13","key":"10.1016\/j.giec.2024.12.009_bib27","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1084\/jem.20061884","article-title":"Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement","volume":"203","author":"Chieppa","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.giec.2024.12.009_bib28","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.3389\/fimmu.2018.02883","article-title":"Intestinal dendritic cells in health and gut inflammation","volume":"9","author":"Stagg","year":"2018","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.giec.2024.12.009_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201900989","article-title":"Circulating dendritic cells from celiac disease patients display a gut-homing profile and are differentially modulated by different gliadin-derived peptides","volume":"64","author":"Escudero-Hernandez","year":"2020","journal-title":"Mol Nutr Food Res"},{"issue":"1","key":"10.1016\/j.giec.2024.12.009_bib30","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41385-021-00448-w","article-title":"Dendritic cell functions in the inductive and effector sites of intestinal immunity","volume":"15","author":"Luciani","year":"2022","journal-title":"Mucosal Immunol"},{"issue":"5","key":"10.1016\/j.giec.2024.12.009_bib31","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.smim.2015.11.001","article-title":"Celiac disease: autoimmunity in response to food antigen","volume":"27","author":"Stamnaes","year":"2015","journal-title":"Semin Immunol"},{"issue":"12","key":"10.1016\/j.giec.2024.12.009_bib32","doi-asserted-by":"crossref","first-page":"e741","DOI":"10.1002\/iid3.741","article-title":"The modulation of macrophage subsets in celiac disease pathogenesis","volume":"10","author":"Molaaghaee-Rouzbahani","year":"2022","journal-title":"Immun Inflamm Dis"},{"issue":"7","key":"10.1016\/j.giec.2024.12.009_bib33","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1053\/j.gastro.2021.02.063","article-title":"B lymphocytes contribute to celiac disease pathogenesis","volume":"160","author":"Lejeune","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.giec.2024.12.009_bib34","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1056\/NEJM196410082711504","article-title":"Significance of antibodies to dietary proteins in the serums of patients with nontropical sprue","volume":"271","author":"Kivel","year":"1964","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.giec.2024.12.009_bib35","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nm0797-797","article-title":"Identification of tissue transglutaminase as the autoantigen of celiac disease","volume":"3","author":"Dieterich","year":"1997","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.giec.2024.12.009_bib36","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/ajg.2013.79","article-title":"ACG clinical guidelines: diagnosis and management of celiac disease","volume":"108","author":"Rubio-Tapia","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.giec.2024.12.009_bib37","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.molimm.2007.09.025","article-title":"Anti-idiotypic response in mice expressing human autoantibodies","volume":"45","author":"Di Niro","year":"2008","journal-title":"Mol Immunol"},{"issue":"4","key":"10.1016\/j.giec.2024.12.009_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0266543","article-title":"Injection of prototypic celiac anti-transglutaminase 2 antibodies in mice does not cause enteropathy","volume":"17","author":"Lindstad","year":"2022","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.giec.2024.12.009_bib39","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.dld.2011.01.015","article-title":"Intestinal deposits of anti-tissue transglutaminase IgA in childhood celiac disease","volume":"43","author":"Maglio","year":"2011","journal-title":"Dig Liver Dis"},{"issue":"2","key":"10.1016\/j.giec.2024.12.009_bib40","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1365-2249.2007.03487.x","article-title":"Antibody responses to deamidated gliadin peptide show high specificity and parallel antibodies to tissue transglutaminase in developing coeliac disease","volume":"150","author":"Ankelo","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.giec.2024.12.009_bib41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0065-2423(07)44002-1","article-title":"Deamidated gliadin peptides as targets for celiac disease-specific antibodies","volume":"44","author":"Mothes","year":"2007","journal-title":"Adv Clin Chem"},{"issue":"1","key":"10.1016\/j.giec.2024.12.009_bib42","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/039463201002300116","article-title":"Isolation and characterization of circulating tissue transglutaminase-specific T cells in coeliac disease","volume":"23","author":"Ciccocioppo","year":"2010","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"6","key":"10.1016\/j.giec.2024.12.009_bib43","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1136\/gut.41.6.851","article-title":"Autoantibodies in coeliac disease: tissue transglutaminase--guilt by association?","volume":"41","author":"Sollid","year":"1997","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.giec.2024.12.009_bib44","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.gastro.2024.03.042","article-title":"New insights on genes, gluten, and immunopathogenesis of celiac disease","volume":"167","author":"Abadie","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.giec.2024.12.009_bib45","series-title":"The rose and mackay textbook of autoimmune diseases","first-page":"775","article-title":"Chapter 39 - celiac disease","author":"Marietta","year":"2024"},{"issue":"2","key":"10.1016\/j.giec.2024.12.009_bib46","first-page":"386","article-title":"HLA-DR, DP and DQ expression in the small intestine of patients with coeliac disease","volume":"70","author":"Marley","year":"1987","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.giec.2024.12.009_bib47","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.immuni.2004.06.018","article-title":"A direct role for NKG2D\/MICA interaction in villous atrophy during celiac disease","volume":"21","author":"Hue","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.giec.2024.12.009_bib48","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.3389\/fimmu.2018.02144","article-title":"Epithelial MHC class II expression and its role in antigen presentation in the gastrointestinal and respiratory tracts","volume":"9","author":"Wosen","year":"2018","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.giec.2024.12.009_bib49","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1053\/j.gastro.2015.05.013","article-title":"Distinct and synergistic contributions of epithelial stress and adaptive immunity to functions of intraepithelial killer cells and active celiac disease","volume":"149","author":"Setty","year":"2015","journal-title":"Gastroenterology"},{"issue":"8024","key":"10.1016\/j.giec.2024.12.009_bib50","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41586-024-07716-2","article-title":"A human autoimmune organoid model reveals IL-7 function in coeliac disease","volume":"632","author":"Santos","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.giec.2024.12.009_bib51","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.3389\/fimmu.2020.01374","article-title":"Coeliac disease pathogenesis: the uncertainties of a well-known immune mediated disorder","volume":"11","author":"Dunne","year":"2020","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.giec.2024.12.009_bib52","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nri3919","article-title":"IL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destruction","volume":"15","author":"Jabri","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"10.1016\/j.giec.2024.12.009_bib53","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.cgh.2012.08.012","article-title":"Intestinal permeability and its regulation by zonulin: diagnostic and therapeutic implications","volume":"10","author":"Fasano","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.giec.2024.12.009_bib54","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1203\/00006450-199012000-00005","article-title":"Intestinal gamma\/delta receptor-bearing T lymphocytes in celiac disease and inflammatory bowel diseases in children. Constant increase in celiac disease","volume":"28","author":"Savilahti","year":"1990","journal-title":"Pediatr Res"},{"issue":"2","key":"10.1016\/j.giec.2024.12.009_bib55","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41385-019-0222-9","article-title":"Single-cell TCR sequencing of gut intraepithelial gammadelta T cells reveals a vast and diverse repertoire in celiac disease","volume":"13","author":"Eggesbo","year":"2020","journal-title":"Mucosal Immunol"},{"issue":"14","key":"10.1016\/j.giec.2024.12.009_bib56","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.3390\/ijms20143400","article-title":"Coeliac disease and mast cells","volume":"20","author":"Frossi","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.giec.2024.12.009_bib57","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1080\/00365521.2020.1775880","article-title":"Duodenal eosinophils as predictors of symptoms in coeliac disease: a comparison of coeliac disease and non-coeliac dyspeptic patients with controls","volume":"55","author":"Potter","year":"2020","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.giec.2024.12.009_bib58","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3389\/fimmu.2019.01290","article-title":"Dermatitis herpetiformis: novel perspectives","volume":"10","author":"Antiga","year":"2019","journal-title":"Front Immunol"},{"issue":"4 Suppl 1","key":"10.1016\/j.giec.2024.12.009_bib59","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1053\/j.gastro.2005.02.026","article-title":"Skin manifestations of celiac disease","volume":"128","author":"Zone","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.giec.2024.12.009_bib60","unstructured":"Hall RP 3rd, Benbenisty KM, Mickle C, et al. Serum IL-8 in patients with dermatitis herpetiformis is produced in response to dietary gluten. (1523-1747 (Electronic))."},{"issue":"1","key":"10.1016\/j.giec.2024.12.009_bib61","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.humimm.2009.09.351","article-title":"Serum cytokine elevations in celiac disease: association with disease presentation","volume":"71","author":"Manavalan","year":"2010","journal-title":"Hum Immunol"},{"issue":"1","key":"10.1016\/j.giec.2024.12.009_bib62","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/07853890.2016.1222450","article-title":"Dermatitis herpetiformis: a cutaneous manifestation of coeliac disease","volume":"49","author":"Collin","year":"2017","journal-title":"Ann Med"},{"issue":"3","key":"10.1016\/j.giec.2024.12.009_bib63","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.coi.2013.02.004","article-title":"Vaccine against autoimmune disease: antigen-specific immunotherapy","volume":"25","author":"Anderson","year":"2013","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"10.1016\/j.giec.2024.12.009_bib64","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S2468-1253(22)00428-9","article-title":"Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 study","volume":"8","author":"Tye-Din","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.giec.2024.12.009_bib65","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1053\/j.gastro.2021.03.014","article-title":"TAK-101 nanoparticles induce gluten-specific tolerance in celiac disease: a randomized, double-blind, placebo-controlled study","volume":"161","author":"Kelly","year":"2021","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.giec.2024.12.009_bib66","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nbt.2434","article-title":"Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis","volume":"30","author":"Getts","year":"2012","journal-title":"Nat Biotechnol"},{"issue":"10","key":"10.1016\/j.giec.2024.12.009_bib67","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41551-019-0424-1","article-title":"Synthetically glycosylated antigens induce antigen-specific tolerance and prevent the onset of diabetes","volume":"3","author":"Wilson","year":"2019","journal-title":"Nat Biomed Eng"},{"issue":"8","key":"10.1016\/j.giec.2024.12.009_bib68","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S2468-1253(23)00107-3","article-title":"Safety and tolerability of KAN-101, a liver-targeted immune tolerance therapy, in patients with coeliac disease (ACeD): a phase 1 trial","volume":"8","author":"Murray","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.giec.2024.12.009_bib69","series-title":"Prevotella histicola preparations and the treatment of autoimmune conditions","author":"Murray","year":"2011"},{"issue":"50","key":"10.1016\/j.giec.2024.12.009_bib70","doi-asserted-by":"crossref","first-page":"20513","DOI":"10.1021\/ja3094795","article-title":"Computational design of an alpha-gliadin peptidase","volume":"134","author":"Gordon","year":"2012","journal-title":"J Am Chem Soc"},{"issue":"1","key":"10.1016\/j.giec.2024.12.009_bib71","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.gastro.2021.03.019","article-title":"Gluten degradation, pharmacokinetics, safety, and tolerability of TAK-062, an engineered enzyme to treat celiac disease","volume":"161","author":"Pultz","year":"2021","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.giec.2024.12.009_bib72","doi-asserted-by":"crossref","first-page":"13100","DOI":"10.1038\/s41598-017-13587-7","article-title":"Randomized clinical trial: effective gluten degradation by Aspergillus Niger-derived enzyme in a complex meal setting","volume":"7","author":"Konig","year":"2017","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.giec.2024.12.009_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109972","article-title":"BL-7010 demonstrates specific binding to gliadin and reduces gluten-associated pathology in a chronic mouse model of gliadin sensitivity","volume":"9","author":"McCarville","year":"2014","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.giec.2024.12.009_bib74","doi-asserted-by":"crossref","first-page":"10815","DOI":"10.3390\/ijms241310815","article-title":"The oral transglutaminase 2 inhibitor ZED1227 accumulates in the villous enterocytes in celiac disease patients during gluten challenge and drug treatment","volume":"24","author":"Isola","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.giec.2024.12.009_bib75","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa2032441","article-title":"A randomized trial of a transglutaminase 2 inhibitor for celiac disease","volume":"385","author":"Schuppan","year":"2021","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.giec.2024.12.009_bib76","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1053\/j.gastro.2015.02.008","article-title":"Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial","volume":"148","author":"Leffler","year":"2015","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.giec.2024.12.009_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2021.101782","article-title":"Larazotide acetate for treatment of celiac disease: a systematic review and meta-analysis of randomized controlled trials","volume":"46","author":"Hoilat","year":"2022","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"12","key":"10.1016\/j.giec.2024.12.009_bib78","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S2468-1253(19)30264-X","article-title":"Safety and efficacy of AMG 714 in adults with coeliac disease exposed to gluten challenge: a phase 2a, randomised, double-blind, placebo-controlled study","volume":"4","author":"Lahdeaho","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.giec.2024.12.009_bib79","doi-asserted-by":"crossref","first-page":"S","DOI":"10.1016\/S0016-5085(24)02155-3","article-title":"Su1326 developing TEV-53408 for the treatment of celiac disease: summary of preliminary results from the first in human phase 1 study in healthy volunteers","volume":"166","author":"Schnir","year":"2024","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.giec.2024.12.009_bib80","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1053\/j.gastro.2019.09.006","article-title":"Community-based study of celiac disease autoimmunity progression in adults","volume":"158","author":"Choung","year":"2020","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.giec.2024.12.009_bib81","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/2050640617751253","article-title":"Delayed celiac disease diagnosis predisposes to reduced quality of life and incremental use of health care services and medicines: a prospective nationwide study","volume":"6","author":"Fuchs","year":"2018","journal-title":"United European Gastroenterol J"},{"issue":"1","key":"10.1016\/j.giec.2024.12.009_bib82","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1053\/j.gastro.2024.02.005","article-title":"A look into the future: are we ready for an approved therapy in celiac disease?","volume":"167","author":"Anderson","year":"2024","journal-title":"Gastroenterology"}],"container-title":["Gastrointestinal Endoscopy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105251572400117X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105251572400117X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T23:03:28Z","timestamp":1761433408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105251572400117X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":82,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S105251572400117X"],"URL":"https:\/\/doi.org\/10.1016\/j.giec.2024.12.009","relation":{},"ISSN":["1052-5157"],"issn-type":[{"value":"1052-5157","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunology in Celiac Disease","name":"articletitle","label":"Article Title"},{"value":"Gastrointestinal Endoscopy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.giec.2024.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}